| Literature DB >> 35936678 |
Jiazhou Yu1, Qi Feng2, Jean H Kim1, Yimin Zhu3,4.
Abstract
Background: In addition to adiposity, lifestyle factors such as poor diet, low physical activity, alcohol intake and smoking are noted to be associated with the development of colorectal cancer (CRC). This study aims to investigate the association and dose-response relationship between adherence to a healthy lifestyle and CRC risk.Entities:
Keywords: colorectal, lifestyle; dose-response; incident; index; prevention
Year: 2022 PMID: 35936678 PMCID: PMC9353059 DOI: 10.3389/fonc.2022.827019
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Flow chart of study selection.
Basic characteristics of the included studies (n=28).
| Study ID | Country | Study design | Sample size | Mean age (range) | Male % | Median follow-up year | Outcomes assessed (n) | Healthy lifestyle components | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diet | Smoking | Alcohol use | Physical activity | Body measure | Other | ||||||||
| Aleksandrova ( | 10 European countries | Cohort | 521330 | 51.8 (25-70) | 35.0 | 12.0 | CRC (3579) | X | X | X | X | X | |
| Barrubes ( | Spain | Cohort | 7216 | 67.0 (62-72) | 57.4 | 6.0 | CRC (101) | X | X | X | X | X | |
| Byrd ( | US | Case-control | 2751 | 55.5 (NA) | 47.5 | NA | CRA (765) | X | X | X | X | ||
| Carr ( | Germany | Case-control | 7124 | 68.2 (32-99) | 60.8 | NA | CRC (4092) | X | X | X | X | X | |
| Cheng ( | US | Cohort | 35221 | 61.7 (55-69) | 0 | >10.0 | CRC (1737) | X | X | X | |||
| Cho ( | South Korea | Case-control | 1927 | 56.1 (NA) | 68.3 | NA | CRC (632) | X | X | X | X | X | |
| Dartois ( | France | Cohort | 64732 | NA (43-68) | 0 | 15.0 | CRC (481) | X | X | X | X | X | |
| Erdrich ( | US | Cohort | 81092 | 63.0 (40-89) | 0 | 24.0 | Colon cancer (1127) | X | X | X | X | X | |
| Erben ( | Germany | Cross-sectional | 13600 | 62.9 (NA) | 50.3 | NA | CRA (2839) | X | X | X | X | X | |
| Fliss-Isakov ( | Israel | Case-control | 788 | 58.8 (NA) | 52.7 | NA | CRA (403) | X | X | X | X | ||
| Fu ( | US | Case-control | 5208 | 57.4 (40-75) | 63.0 | NA | Advanced CRA (386) | X | X | X | X | ||
| Hang ( | China | Case-control | 61693 | 68.9 (23-98) | 45.2 | NA | CRC (1144) | X | X | X | X | ||
| Harnack ( | US | Cohort | 34708 | 61.7 (55-69) | 0 | 13.0 | Colon cancer (619) | X | X | X | X | ||
| Hastert ( | US | Cohort | 66920 | 61.1 (50-76) | 49.0 | 7.6 | CRC (546) | X | X | X | X | ||
| Hatime ( | Morocco | Case-control | 2906 | 56.0 (NA) | 49.3 | NA | CRC (1453) | X | X | X | X | X | |
| Inoue-Choi ( | US | Cohort | 2017 | 78.9 (72-88) | 0 | 5.4 | CRC-specific mortality (23) | X | X | X | X | ||
| Jones ( | UK | Cohort | 30963 | 52.3 (NA) | 0 | 18.7 | CRC (444) | X | X | X | X | X | |
| Kirkegaard ( | Denmark | Cohort | 55487 | 56.0 (50-64) | 48.0 | 9.9 | CRC (678) | X | X | X | X | X | |
| Knudsen ( | Norway | Cross-sectional | 6315 | 62.0 (NA) | 48.0 | NA | Advanced colorectal neoplasia (311) | X | X | X | X | X | |
| Lohse ( | Switzerland | Cohort | 16722 | 46.1 (25-74) | 48.8 | 21.7 | CRC-specific mortality (79) | X | X | X | X | ||
| Nomura ( | US | Cohort | 49103 | 38.2 (21-69) | 0 | 15.1 | CRC (328) | X | X | X | X | ||
| Odegaard ( | Singapore | Cohort | 50466 | 55.9 (45-74) | 46.4 | 11.5 | CRC (969) | X | X | X | X | X | X |
| Petimar ( | US | Cohort | 45442 | 52.8 (40-75) | 100 | >24.0 | CRC (1151) | X | X | X | X | ||
| Petimar ( | US | Cohort | 68977 | 52.8 (30-55) | 0 | >24.0 | CRC (1298) | X | X | X | X | ||
| Romaguera ( | 10 European countries | Cohort | 3292 | 64.6 (NA) | 45.5 | 4.2 | CRC-specific mortality (872) | X | X | X | X | X | |
| Sotos-Prieto ( | US | Cohort | 87113 | 51.7 (40-75) | 66.9 | NA | CRC-specific mortality (684) | X | X | X | X | X | |
| Tabung ( | US | Case-control | 138 | NA (30-80) | 49.3 | NA | CRA (47) | X | X | X | X | X | |
| Thomson ( | US | Cohort | 65838 | 63.2 (50-79) | 0 | 12.6 | CRC (751) | X | X | X | X | ||
| Zhang ( | China | Cohort | 59503 | 55.3 (40-74) | 100 | 9.3 | CRC (674) | X | X | X | X | ||
Sleeping duration included as a component;
Breastfeeding (applicable to women) included as a component;
Petimar 2019 reported outcome on males and females separately and was therefore included as two separated studies in analysis;
mean follow-up;
Regular nonsteroidal anti-inflammatory drug use; CRC, colorectal cancer; CRA, colorectal adenoma; NA, not available.
Figure 2The forest plots of risk of CRC, colon cancer, rectal cancer, CRA, advanced colorectal neoplasia, and CRC-specific mortality.
Figure 3(A) Line graph of association between healthy lifestyles and risk for CRC; dose-response relationship between the number of healthy lifestyles and the risk for CRC: (B) Linear trend; (C) Restricted cubic splines.
Figure 4The results of the subgroup analyses for risk of CRC.